Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Origin recognition complex subunit 3 (ORC3)
- Target
- ORC3
- Molecular classification
- DNA-binding protein, Replication complex subunit, Other (multi-protein complex subunit; not a receptor, transporter, ion channel, or enzyme)
01
Overview
Origin recognition complex subunit 3 (ORC3) is one of six components of the origin recognition complex (ORC), which is required for the initiation of DNA replication in all eukaryotic cells[1][3][5]. ORC3 is a DNA-binding protein that helps identify and mark origins of replication, serving as a template for assembling the pre-replication complex with other factors such as CDC6 and MCM proteins. ORC3 also plays key roles in chromatin structure via interactions with methylated histones and chromatin proteins[2][5]. In Drosophila and mammals, ORC3 is involved in neurogenesis, neuronal differentiation, and synaptic function, with evidence linking mutations to altered memory and learning[2][7]. The subunit’s crucial role in cell cycle regulation means it is not a direct therapeutic target, and perturbation typically results in cell death or developmental disorders[5][6].
- Other names
- ORC3Latheo (especially in Drosophila)ORC3LLATLATHEOOrigin recognition complex subunit LatheoOrigin recognition complex subunit 3, homolog of latheo, Drosophila
02
Mechanism of action
Not applicable. No drugs are known to modulate this subunit directly
03
Biological functions
Initiation of DNA replication (binds to origins of replication and assembles pre-replication complex)Chromatin organization and heterochromatin formation (interacts with histone marks and heterochromatin proteins)Neurogenesis and neuronal differentiation (implicated in dendrite growth, synaptic plasticity, and memory formation, particularly in Drosophila and mammals)
04
Disease associations
Meier-Gorlin syndrome (mutations can cause this rare developmental disorder)Non-Syndromic Pontocerebellar HypoplasiaOther neurodevelopmental conditions (as suggested by animal studies, but limited direct evidence in humans)
05
Safety considerations
ORC3 is essential for cell viability as it is involved in DNA replication; therefore, inhibition would likely impair cell division and be cytotoxicMutations in ORC3 cause rare developmental syndromes, suggesting clinical safety concerns in gene editing or modulation
Beyond the preview
Go deeper on Origin recognition complex subunit 3 (ORC3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Origin recognition complex subunit 3 (ORC3).